siRNA delivery: From basics to therapeutic applications

Frontiers in Bioscience

Volumn 18, Issue 1, 2013, Pages 58-79

  Musacchio, Tiziana ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Bioconjugates; Carbonanotubes; Clinical trials; Dendrimers; Lipid based particles; Liposomes; Micelles; Nanogels; Polymer based particles; Review; siRNA; siRNA conjugate; siRNA delivery systems

Indexed keywords

BACTERIOPHAGE T7 RNA POLYMERASE; DNA DIRECTED RNA POLYMERASE; MACROGOL DERIVATIVE; MESSENGER RNA; NANOPARTICLE; SMALL INTERFERING RNA; VIRUS PROTEIN;

DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG STABILITY; HUMAN; METABOLISM; METHODOLOGY; MICELLE; REVIEW; RNA INTERFERENCE;

DNA-DIRECTED RNA POLYMERASES; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; MICELLES; NANOPARTICLES; POLYETHYLENE GLYCOLS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; VIRAL PROTEINS;

MLCS; MLOWN;

EID: 84878773916     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4087     Document Type: Review

References (141)

1. D. De Paula, M.V. Bentley, and R.I. Mahato. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA. 13:431-456 (2007)
2. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494-498 (2001)
3. A.J. HamiltonD.C. Baulcombe. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science. 286:950-952 (1999)
4. J.H. Jeong, H. Mok, Y.K. Oh, and T.G. Park. siRNA conjugate delivery systems. Bioconjug Chem. 20:5-14 (2009)
5. Y. DorsettT. Tuschl. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov. 3:318-329 (2004)
6. D.J. Gary, N. Puri, and Y.Y. Won. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release. 121:64-73 (2007)
7. T.C. Chu, K.Y. Twu, A.D. Ellington, and M. Levy. Aptamer mediated siRNA delivery. Nucleic Acids Res. 34:e73 (2006)
8. S.H. Kim, J.H. Jeong, S.H. Lee, S.W. Kim, and T.G. Park. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release. 116:123-129 (2006)
9. C. Lorenz, P. Hadwiger, M. John, H.P. Vornlocher, and C. Unverzagt. Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg Med Chem Lett. 14:4975-4977 (2004)
10. S.A. Moschos, S.W. Jones, M.M. Perry, A.E. Williams, J.S. Erjefalt, J.J. Turner, P.J. Barnes, B.S. Sproat, M.J. Gait, and M.A. Lindsay. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug Chem. 18:1450-1459 (2007)
11. A. MuratovskaM.R. Eccles. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 558:63-68 (2004)
12. K. Nishina, T. Unno, Y. Uno, T. Kubodera, T. Kanouchi, H. Mizusawa, and T. Yokota. Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol. Mol Ther. 16:734-740 (2008)
13. J. Soutschek, A. Akinc, B. Bramlage, K. Charisse, R. Constien, M. Donoghue, S. Elbashir, A. Geick, P. Hadwiger, J. Harborth, M. John, V. Kesavan, G. Lavine, R.K. Pandey, T. Racie, K.G. Rajeev, I. Rohl, I. Toudjarska, G. Wang, S. Wuschko, D. Bumcrot, V. Koteliansky, S. Limmer, M. Manoharan, and H.P. Vornlocher. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature. 432:173-178 (2004)
14. C. Napoli, C. Lemieux, and R. Jorgensen. Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans. Plant Cell. 2:279-289 (1990)
15. A.R. van der Krol, L.A. Mur, M. Beld, J.N. Mol, and A.R. Stuitje. Flavonoid genes in petunia: addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell. 2:291-299 (1990)
16. M. Wassenegger, S. Heimes, L. Riedel, and H.L. Sanger. RNA-directed de novo methylation of genomic sequences in plants. Cell. 76:567-576 (1994)
17. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:806-811 (1998)
18. F. Ratcliff, B.D. Harrison, and D.C. Baulcombe. A similarity between viral defense and gene silencing in plants. Science. 276:1558-1560 (1997)
19. E.P. MurchisonG.J. Hannon. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol. 16:223-229 (2004)
20. P.D. ZamoreB. Haley. Ribo-gnome: the big world of small RNAs. Science. 309:1519-1524 (2005)
21. S. Oliveira, G. Storm, and R.M. Schiffelers. Targeted delivery of siRNA. J Biomed Biotechnol. 2006:63675 (2006)
22. P.A. Sharp. RNAi and double-strand RNA. Genes Dev. 13:139-141 (1999)
23. N.J. Caplen. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Ther. 11:1241-1248 (2004)
24. T. Holen, M. Amarzguioui, M.T. Wiiger, E. Babaie, and H. Prydz. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res. 30:1757-1766 (2002)
25. J. Ji, M. Wernli, T. Klimkait, and P. Erb. Enhanced gene silencing by the application of multiple specific small interfering RNAs. FEBS Lett. 552:247-252 (2003)
26. O. DonzeD. Picard. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res. 30:e46 (2002)
27. J.F. MilliganO.C. Uhlenbeck. Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 180:51-62 (1989)
28. D.H. Kim, M. Longo, Y. Han, P. Lundberg, E. Cantin, and J.J. Rossi. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol. 22:321-325 (2004)
29. M. Amarzguioui, J.J. Rossi, and D. Kim. Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett. 579:5974-5981 (2005)
30. D.M. Dykxhoorn, C.D. Novina, and P.A. Sharp. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol. 4:457-467 (2003)
31. D.A. Rubinson, C.P. Dillon, A.V. Kwiatkowski, C. Sievers, L. Yang, J. Kopinja, D.L. Rooney, M. Zhang, M.M. Ihrig, M.T. McManus, F.B. Gertler, M.L. Scott, and L. Van Parijs. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 33:401-406 (2003)
32. C.M. Liu, D.P. Liu, W.J. Dong, and C.C. Liang. Retrovirus vector-mediated stable gene silencing in human cell. Biochem Biophys Res Commun. 313:716-720 (2004)
33. X. Wu, Y. Li, B. Crise, and S.M. Burgess. Transcription start regions in the human genome are favored targets for MLV integration. Science. 300:1749-1751 (2003)
34. D. GrimmM.A. Kay. Therapeutic short hairpin RNA expression in the liver: viral targets and vectors. Gene Ther. 13:563-575 (2006)
35. M. Sioud. Therapeutic siRNAs. Trends Pharmacol Sci. 25:22-28 (2004)
36. T.R. Brummelkamp, R. Bernards, and R. Agami. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:550-553 (2002)
37. P.J. Paddison, A.A. Caudy, E. Bernstein, G.J. Hannon, and D.S. Conklin. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16:948-958 (2002)
38. C.P. Paul, P.D. Good, I. Winer, and D.R. Engelke. Effective expression of small interfering RNA in human cells. Nat Biotechnol. 20:505-508 (2002)
39. F. Czauderna, A. Santel, M. Hinz, M. Fechtner, B. Durieux, G. Fisch, F. Leenders, W. Arnold, K. Giese, A. Klippel, and J. Kaufmann. Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res. 31:e127 (2003)
40. S. Gupta, R.A. Schoer, J.E. Egan, G.J. Hannon, and V. Mittal. Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci U S A. 101:1927-1932 (2004)
41. J. OhkawaK. Taira. Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter. Hum Gene Ther. 11:577-585 (2000)
42. S. Matsukura, P.A. Jones, and D. Takai. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 31:e77 (2003)
43. T. Christoph, A. Grunweller, J. Mika, M.K. Schafer, E.J. Wade, E. Weihe, V.A. Erdmann, R. Frank, C. Gillen, and J. Kurreck. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo. Biochem Biophys Res Commun. 350:238-243 (2006)
44. S.Q. Harper, P.D. Staber, X. He, S.L. Eliason, I.H. Martins, Q. Mao, L. Yang, R.M. Kotin, H.L. Paulson, and B.L. Davidson. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci U S A. 102:5820-5825 (2005)
45. E. Rodriguez-Lebron, E.M. Denovan-Wright, K. Nash, A.S. Lewin, and R.J. Mandel. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. Mol Ther. 12:618-633 (2005)
46. A.M. Gewirtz. RNA targeted therapeutics for hematologic malignancies. Blood Cells Mol Dis. 38:117-119 (2007)
47. T. RohlJ. Kurreck. RNA interference in pain research. J Neurochem. 99:371-380 (2006)
48. S.P. Persengiev, X. Zhu, and M.R. Green. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs) RNA. 10:12-18 (2004)
49. R. Juliano, J. Bauman, H. Kang, and X. Ming. Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol Pharm. 6:686-695 (2009)
50. D.M. MosserJ.P. Edwards. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 8:958-969 (2008)
51. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 5:505-515 (2008)
52. T.L. Jason, J. Koropatnick, and R.W. Berg. Toxicology of antisense therapeutics. Toxicol Appl Pharmacol. 201:66-83 (2004)
53. J. Zabner, A.J. Fasbender, T. Moninger, K.A. Poellinger, and M.J. Welsh. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem. 270:18997-19007 (1995)
54. M. DominskaD.M. Dykxhoorn. Breaking down the barriers: siRNA delivery and endosome escape. J Cell Sci. 123:1183-1189 (2010)
55. C.N. Landen, Jr., A. Chavez-Reyes, C. Bucana, R. Schmandt, M.T. Deavers, G. Lopez-Berestein, and A.K. Sood. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65:6910-6918 (2005)
56. T.S. Zimmermann, A.C. Lee, A. Akinc, B. Bramlage, D. Bumcrot, M.N. Fedoruk, J. Harborth, J.A. Heyes, L.B. Jeffs, M. John, A.D. Judge, K. Lam, K. McClintock, L.V. Nechev, L.R. Palmer, T. Racie, I. Rohl, S. Seiffert, S. Shanmugam, V. Sood, J. Soutschek, I. Toudjarska, A.J. Wheat, E. Yaworski, W. Zedalis, V. Koteliansky, M. Manoharan, H.P. Vornlocher, and I. MacLachlan. RNAi-mediated gene silencing in non-human primates. Nature. 441:111-114 (2006)
57. B. Urban-Klein, S. Werth, S. Abuharbeid, F. Czubayko, and A. Aigner. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12:461-466 (2005)
58. A.L. Jackson, J. Burchard, D. Leake, A. Reynolds, J. Schelter, J. Guo, J.M. Johnson, L. Lim, J. Karpilow, K. Nichols, W. Marshall, A. Khvorova, and P.S. Linsley. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA. 12:1197-1205 (2006)
59. Y.L. ChiuT.M. Rana. siRNA function in RNAi: a chemical modification analysis. RNA. 9:1034-1048 (2003)
60. J.M. Layzer, A.P. McCaffrey, A.K. Tanner, Z. Huang, M.A. Kay, and B.A. Sullenger. In vivo activity of nuclease-resistant siRNAs. RNA. 10:766-771 (2004)
61. J. Elmen, H. Thonberg, K. Ljungberg, M. Frieden, M. Westergaard, Y. Xu, B. Wahren, Z. Liang, H. Orum, T. Koch, and C. Wahlestedt. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 33:439-447 (2005)
62. V. Hornung, M. Guenthner-Biller, C. Bourquin, A. Ablasser, M. Schlee, S. Uematsu, A. Noronha, M. Manoharan, S. Akira, A. de Fougerolles, S. Endres, and G. Hartmann. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med. 11:263-270 (2005)
63. M. Manoharan. RNA interference and chemically modified small interfering RNAs. Curr Opin Chem Biol. 8:570-579 (2004)
64. R.I. Mahato, K. Cheng, and R.V. Guntaka. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA. Expert Opin Drug Deliv. 2:3-28 (2005)
65. A.H. Hall, J. Wan, E.E. Shaughnessy, B. Ramsay Shaw, and K.A. Alexander. RNA interference using boranophosphate siRNAs: structure-activity relationships. Nucleic Acids Res. 32:5991-6000 (2004)
66. A. Khvorova, A. Reynolds, and S.D. Jayasena. Functional siRNAs and miRNAs exhibit strand bias. Cell. 115:209-216 (2003)
67. D.S. Schwarz, G. Hutvagner, T. Du, Z. Xu, N. Aronin, and P.D. Zamore. Asymmetry in the assembly of the RNAi enzyme complex. Cell. 115:199-208 (2003)
68. T. Musacchio, O. Vaze, G. D'Souza, and V.P. Torchilin. Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. Bioconjug Chem. 21:1530-1536 (2010)
69. S. Grijalvo, S.M. Ocampo, J.C. Perales, and R. Eritja. Synthesis of oligonucleotides carrying amino lipid groups at the 3′-end for RNA interference studies. J Org Chem. 75:6806-6813 (2010)
70. Q. Chen, D. Butler, W. Querbes, R.K. Pandey, P. Ge, M.A. Maier, L. Zhang, K.G. Rajeev, L. Nechev, V. Kotelianski, M. Manoharan, and D.W. Sah. Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery. J Control Release. 144:227-232 (2010)
71. C. Wolfrum, S. Shi, K.N. Jayaprakash, M. Jayaraman, G. Wang, R.K. Pandey, K.G. Rajeev, T. Nakayama, K. Charrise, E.M. Ndungo, T. Zimmermann, V. Koteliansky, M. Manoharan, and M. Stoffel. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol. 25:1149-1157 (2007)
72. M. Lindgren, M. Hallbrink, A. Prochiantz, and U. Langel. Cell-penetrating peptides. Trends Pharmacol Sci. 21:99-103 (2000)
73. A. Prochiantz. Messenger proteins: homeoproteins, TAT and others. Curr Opin Cell Biol. 12:400-406 (2000)
74. V.P. Torchilin, T.S. Levchenko, R. Rammohan, N. Volodina, B. Papahadjopoulos-Sternberg, and G.G. D'Souza. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A. 100:1972-1977 (2003)
75. R. SawantV. Torchilin. Intracellular delivery of nanoparticles with CPPs. Methods Mol Biol. 683:431-451 (2011)
76. R.I. Mahat, O.D. Monera, L.C. Smith, and A. Rolland. Peptide-based gene delivery. Curr Opin Mol Ther. 1:226-243 (1999)
77. E. Vives, P. Brodin, and B. Lebleu. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 272:16010-16017 (1997)
78. Y.L. Chiu, A. Ali, C.Y. Chu, H. Cao, and T.M. Rana. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem Biol. 11:1165-1175 (2004)
79. S. Meng, B. Wei, R. Xu, K. Zhang, L. Wang, R. Zhang, and J. Li. TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication. Intervirology. 52:135-140 (2009)
80. T.J. Davidson, S. Harel, V.A. Arboleda, G.F. Prunell, M.L. Shelanski, L.A. Greene, and C.M. Troy. Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. J Neurosci. 24:10040-10046 (2004)
81. S.H. Kim, J.H. Jeong, S.H. Lee, S.W. Kim, and T.G. Park. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Bioconjug Chem. 19:2156-2162 (2008)
82. M. Oishi, F. Nagatsugi, S. Sasaki, Y. Nagasaki, and K. Kataoka. Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages. Chembiochem. 6:718-725 (2005)
83. S. Jung, S.H. Lee, H. Mok, H.J. Chung, and T.G. Park. Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight. J Control Release. 144:306-313 (2010)
84. S.H. Lee, H. Mok, and T.G. Park. Di- and Triblock siRNA-PEG Copolymers: PEG Density Effect of Polyelectrolyte Complexes on Cellular Uptake and Gene Silencing Efficiency. Macromol Biosci (2010)
85. S.W. Choi, S.H. Lee, H. Mok, and T.G. Park. Multifunctional siRNA delivery system: polyelectrolyte complex micelles of six-arm PEG conjugate of siRNA and cell penetrating peptide with crosslinked fusogenic peptide. Biotechnol Prog. 26:57-63 (2010)
86. S.H. Lee, S.H. Kim, and T.G. Park. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Biochem Biophys Res Commun. 357:511-516 (2007)
87. L. ZhuR.I. Mahato. Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation. Bioconjug Chem. 21:2119-2127 (2010)
88. M. Oishi, Y. Nagasaki, K. Itaka, N. Nishiyama, and K. Kataoka. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc. 127:1624-1625 (2005)
89. H. Lee, I.K. Kim, and T.G. Park. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis. Bioconjug Chem. 21:289-295 (2010)
90. K.H. Bae, K. Lee, C. Kim, and T.G. Park. Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials. 32:176-184 (2011)
91. L. Zhuang, R.A. Scolyer, C.S. Lee, S.W. McCarthy, W.A. Cooper, X.D. Zhang, J.F. Thompson, and P. Hersey. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology. 54:462-470 (2009)
92. O. Taratula, O. Garbuzenko, R. Savla, Y.A. Wang, H. He, and T. Minko. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr Drug Deliv. 8:59-69 (2011)
93. W.H. Blackburn, E.B. Dickerson, M.H. Smith, J.F. McDonald, and L.A. Lyon. Peptide-functionalized nanogels for targeted siRNA delivery. Bioconjug Chem. 20:960-968 (2009)
94. T. Tanaka, L.S. Mangala, P.E. Vivas-Mejia, R. Nieves-Alicea, A.P. Mann, E. Mora, H.D. Han, M.M. Shahzad, X. Liu, R. Bhavane, J. Gu, J.R. Fakhoury, C. Chiappini, C. Lu, K. Matsuo, B. Godin, R.L. Stone, A.M. Nick, G. Lopez-Berestein, A.K. Sood, and M. Ferrari. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res. 70:3687-3696 (2010)
95. C. Zhang, N. Tang, X. Liu, W. Liang, W. Xu, and V.P. Torchilin. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. J Control Release. 112:229-239 (2006)
96. D.S. Benoit, S.M. Henry, A.D. Shubin, A.S. Hoffman, and P.S. Stayton. pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1. Mol Pharm. 7:442-455 (2010)
97. B.K. Nanjwade, H.M. Bechra, G.K. Derkar, F.V. Manvi, and V.K. Nanjwade. Dendrimers: emerging polymers for drug-delivery systems. Eur J Pharm Sci. 38:185-196 (2009)
98. X.C. Shen, J. Zhou, X. Liu, J. Wu, F. Qu, Z.L. Zhang, D.W. Pang, G. Quelever, C.C. Zhang, and L. Peng. Importance of size-to-charge ratio in construction of stable and uniform nanoscale RNA/dendrimer complexes. Org Biomol Chem. 5:3674-3681 (2007)
99. P. Ofek, W. Fischer, M. Calderon, R. Haag, and R. Satchi-Fainaro. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers. FASEB J. 24:3122-3134 (2010)
100. M.L. Patil, M. Zhang, O. Taratula, O.B. Garbuzenko, H. He, and T. Minko. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules. 10:258-266 (2009)
101. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 92:7297-7301 (1995)
102. N.D. Sonawane, F.C. Szoka, Jr., and A.S. Verkman. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem. 278:44826-44831 (2003)
103. A. Agrawal, D.H. Min, N. Singh, H. Zhu, A. Birjiniuk, G. von Maltzahn, T.J. Harris, D. Xing, S.D. Woolfenden, P.A. Sharp, A. Charest, and S. Bhatia. Functional delivery of siRNA in mice using dendriworms. ACS Nano. 3:2495-2504 (2009)
104. N.W. Kam, Z. Liu, and H. Dai. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc. 127:12492-12493 (2005)
105. Z. Liu, M. Winters, M. Holodniy, and H. Dai. siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl. 46:2023-2027 (2007)
106. K.T. Al-Jamal, F.M. Toma, A. Yilmazer, H. Ali-Boucetta, A. Nunes, M.A. Herrero, B. Tian, A. Eddaoui, W.T. Al-Jamal, A. Bianco, M. Prato, and K. Kostarelo. Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes. FASEB J. 24:4354-4365 (2010)
107. E.B. Dickerson, W.H. Blackburn, M.H. Smith, L.B. Kapa, L.A. Lyon, and J.F. McDonald. Chemosensitization of cancer cells by siRNA using targeted nanogel delivery. BMC Cancer. 10:10 (2010)
108. A. Tamura, M. Oishi, and Y. Nagasaki. Efficient siRNA delivery based on PEGylated and partially quaternized polyamine nanogels: enhanced gene silencing activity by the cooperative effect of tertiary and quaternary amino groups in the core. J Control Release. 146:378-387 (2010)
109. H. Lee, H. Mok, S. Lee, Y.K. Oh, and T.G. Park. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release. 119:245-252 (2007)
110. W.H. BlackburnL.A. Lyon. Size Controlled Synthesis of Monodispersed, Core/Shell Nanogels. Colloid Polym Sci. 286:563-569 (2008)
111. I. Berndt, C. Popescu, F.J. Wortmann, and W. Richtering. Mechanics versus thermodynamics: swelling in multiple-temperature-sensitive core-shell microgels. Angew Chem Int Ed Engl. 45:1081-1085 (2006)
112. K. Raemdonck, B. Naeye, A. Hogset, J. Demeester, and S.C. De Smedt. Prolonged gene silencing by combining siRNA nanogels and photochemical internalization. J Control Release. 145:281-288 (2010)
113. K.G. de Bruin, C. Fella, M. Ogris, E. Wagner, N. Ruthardt, and C. Brauchle. Dynamics of photoinduced endosomal release of polyplexes. J Control Release. 130:175-182 (2008)
114. K. Berg, M. Folini, L. Prasmickaite, P.K. Selbo, A. Bonsted, B.O. Engesaeter, N. Zaffaroni, A. Weyergang, A. Dietze, G.M. Maelandsmo, E. Wagner, O.J. Norum, and A. Hogset. Photochemical internalization: a new tool for drug delivery. Curr Pharm Biotechnol. 8:362-372 (2007)
115. X. Zheng, C. Vladau, X. Zhang, M. Suzuki, T.E. Ichim, Z.X. Zhang, M. Li, E. Carrier, B. Garcia, A.M. Jevnikar, and W.P. Min. A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood. 113:2646-2654 (2009)
116. Y.L. Tseng, J.J. Liu, and R.L. Hong. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol Pharmacol. 62:864-872 (2002)
117. K.F. PirolloE.H. Chang. Targeted delivery of small interfering RNA: approaching effective cancer therapies. Cancer Res. 68:1247-1250 (2008)
118. W. Wang, N. Tang, C.L. Zhang, X.J. Liu, H. Hu, Z.X. Zhang, and W. Liang. [Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in Pegylated liposomes]. Yao Xue Xue Bao. 41:142-148 (2006)
119. F. Pastorino, C. Brignole, D. Di Paolo, B. Nico, A. Pezzolo, D. Marimpietri, G. Pagnan, F. Piccardi, M. Cilli, R. Longhi, D. Ribatti, A. Corti, T.M. Allen, and M. Ponzoni. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy. Cancer Res. 66:10073-10082 (2006)
120. V. Petrenko. Evolution of phage display: from bioactive peptides to bioselective nanomaterials. Expert Opin Drug Deliv. 5:825-836 (2008)
121. D. Bedi, T. Musacchio, O.A. Fagbohun, J.W. Gillespie, P. Deinnocentes, R.C. Bird, L. Bookbinder, V.P. Torchilin, and V.A. Petrenko. Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. Nanomedicine (2010)
122. A.L. Cardoso, P. Costa, L.P. de Almeida, S. Simoes, N. Plesnila, C. Culmsee, E. Wagner, and M.C. de Lima. Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo. J Control Release. 142:392-403 (2010)
123. Y. Lee, S.H. Lee, J.S. Kim, A. Maruyama, X. Chen, and T.G. Park. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. J Control Release (2010)
124. A.M. Al-Abd, S.H. Lee, S.H. Kim, J.H. Cha, T.G. Park, S.J. Lee, and H.J. Kuh. Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro. J Control Release. 137:130-135 (2009)
125. C. Zhu, S. Jung, S. Luo, F. Meng, X. Zhu, T.G. Park, and Z. Zhong. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials. 31:2408-2416 (2010)
126. S. Matsumoto, R.J. Christie, N. Nishiyama, K. Miyata, A. Ishii, M. Oba, H. Koyama, Y. Yamasaki, and K. Kataoka. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules. 10:119-127 (2009)
127. A. MeisterM.E. Anderson. Glutathione. Annu Rev Biochem. 52:711-760 (1983)
128. C.R. Dass. Vehicles for oligonucleotide delivery to tumours. J Pharm Pharmacol. 54:3-27 (2002)
129. C.J. Mann, K. Honeyman, A.J. Cheng, T. Ly, F. Lloyd, S. Fletcher, J.E. Morgan, T.A. Partridge, and S.D. Wilton. Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci U S A. 98:42-47 (2001)
130. Y. Kim, M. Tewari, J.D. Pajerowski, S. Cai, S. Sen, J.H. Williams, S.R. Sirsi, G.J. Lutz, and D.E. Discher. Polymersome delivery of siRNA and antisense oligonucleotides. J Control Release. 134:132-140 (2009)
131. F. Ahmed, R.I. Pakunlu, G. Srinivas, A. Brannan, F. Bates, M.L. Klein, T. Minko, and D.E. Discher. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol Pharm. 3:340-350 (2006)
132. S. Cai, K. Vijayan, D. Cheng, E.M. Lima, and D.E. Discher. Micelles of different morphologies - advantages of worm-like filomicelles of PEO-PCL in paclitaxel delivery. Pharm Res. 24:2099-2109 (2007)
133. H. Ye, Y. Qian, M. Lin, Y. Duan, X. Sun, Y. Zhuo, and J. Ge. Cationic nano-copolymers mediated IKKbeta targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery. Mol Vis. 16:2502-2510 (2010)
134. L. Gu, H. Chen, J. Tuo, X. Gao, and L. Chen. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Exp Eye Res. 91:433-439 (2010)
135. B. Pulford, N. Reim, A. Bell, J. Veatch, G. Forster, H. Bender, C. Meyerett, S. Hafeman, B. Michel, T. Johnson, A.C. Wyckoff, G. Miele, C. Julius, J. Kranich, A. Schenkel, S. Dow, and M.D. Zabel. Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures. PLoS One. 5:e11085 (2010)
136. I.D. Kim, C.M. Lim, J.B. Kim, H.Y. Nam, K. Nam, S.W. Kim, J.S. Park, and J.K. Lee. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. J Control Release. 142:422-430 (2010)
137. E.J. Nielsen, J.M. Nielsen, D. Becker, A. Karlas, H. Prakash, S.Z. Glud, J. Merrison, F. Besenbacher, T.F. Meyer, J. Kjems, and K.A. Howard. Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles. Pharm Res. 27:2520-2527 (2010)
138. B. Ghosn, A. Singh, M. Li, A.V. Vlassov, C. Burnett, N. Puri, and K. Roy. Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA. Oligonucleotides. 20:163-172 (2010)
139. T. Adachi, E. Kawakami, N. Ishimaru, T. Ochiya, Y. Hayashi, H. Ohuchi, M. Tanihara, E. Tanaka, and S. Noji. Delivery of small interfering RNA with a synthetic collagen poly(Pro-Hyp-Gly) for gene silencing in vitro and in vivo. Dev Growth Differ. 52:693-699 (2010)
140. M. GolzioJ. Teissie. Optical in vivo imaging of electrically mediated delivery of siRNA into muscle for gene function analysis. Methods Mol Biol. 423:279-287 (2008)
141. J.H. Kang, Y. Tachibana, W. Kamata, A. Mahara, M. Harada-Shiba, and T. Yamaoka. Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier. Bioorg Med Chem. 18:3946-3950 (2010)